Project Grant R01DK145735
Award Date 3/15/26
Completion Date 1/31/30
Dollars Obligated $762K
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Boston, MA 02114, USA
Similar Awards
- Federal Project Grant Award Summary Massachusetts General Hospital received a $133,328 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 20, 2025 through September 19, 2026. The award supports research investigating the distinct roles of PPM1D and TP53 mutations in hematopoietic stem cells and clonal hematopoiesis (CH)—the...
- Federal Project Grant Award Summary Boston Children's Hospital received a $469,042 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 1, 2025, through August 31, 2027. The award funds the transformation and optimization of a human induced pluripotent stem cell (iPSC)-derived bone marrow organoid model for studying hematopoiesis. The...
- Federal Project Grant Award Summary Massachusetts General Hospital received a $661,694 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on September 3, 2025. The award, with a completion date of June 30, 2029, funds research to understand the non-canonical role of FANCD2 (Fanconi Anemia Complementation Group D2) as a transcriptional regulator in kidney...
- Federal Grant Award Summary Boston Children's Hospital received a $154,860 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded August 1, 2025, with completion anticipated by May 31, 2028. The grant funds research investigating the mechanisms of clonal competition in age-related clonal hematopoiesis (CH), a condition where hematopoietic stem cells...
- Federal Project Grant Award Summary The Children's Hospital Corporation, operating as Boston Children's Hospital, received a $801,000 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award was obligated on September 15, 2025, with a completion date of July 31, 2030. This research initiative, conducted at the institution's Boston, Massachusetts facility,...
- Federal Grant Award Summary This Project Grant, awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), provides $453,750 in federal funding to Massachusetts General Hospital for basic biomedical research investigating the interconnections between one-carbon metabolism, S-adenosyl-methionine (SAM) availability, and chromatin methylation. The research award, effective June 1, 2025 through April 30, 2030, will...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Massachusetts General Hospital a $813,961 Project Grant effective February 1, 2026, through November 30, 2030, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research focuses on elucidating bone morphogenetic protein (BMP) 2 and BMP6 ligand formation and function in development and iron homeostasis. The project investigates critical...
- Federal Project Grant Award Summary Harvard Medical School received an $830,414 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective August 13, 2025, with a completion date of June 30, 2030. The award supports research focused on identifying and characterizing microbiome-derived sulfated metabolites and their biological effects on human...
- Federal Project Grant Award Summary Massachusetts General Hospital received a $110,865 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective April 1, 2026 through March 31, 2031. The award funds investigator-initiated research examining c-kit receptor signaling in the modulation of kidney collecting duct function. The research aims to elucidate the...
- Federal Grant Award Summary Dana-Farber Cancer Institute, Inc. received a $740,581 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded April 1, 2026, with completion targeted for January 31, 2031. The grant funds basic biomedical research investigating the niche regulation of gastric epithelial cell differentiation, specifically examining how...